Publication Name	World Journal of Gastrointestinal Oncology
Manuscript ID	107815
Country	China

Received	2025-04-01 15:06
Peer-Review Started	2025-04-01 15:06
To Make the First Decision
Return for Revision	2025-04-16 10:22
Revised	2025-04-30 16:11
Second Decision	2025-06-19 02:38
Accepted by Journal Editor-in-Chief
Accepted by Executive Editor-in-Chief	2025-06-19 06:32
Articles in Press	2025-06-19 06:32
Publication Fee Transferred
Edit the Manuscript by Language Editor
Typeset the Manuscript	2025-07-02 02:23
Publish the Manuscript Online	2025-07-14 12:56

ISSN	1948-5204 (online)
Open Access	This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Copyright	© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved.
Article Reprints	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
Permissions	For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
Publisher	Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
Website	http://www.wjgnet.com

Category	Gastroenterology & Hepatology
Manuscript Type	Review
Article Title	Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence
Manuscript Source	Invited Manuscript
All Author List	Qian-Jia Liu, Jia-Cheng Zhang, Yue-Fan Wang, Ming-Hao Zou, Wen-Xuan Zhou, Yan Lu, Xiao-Chen Feng and Hui Liu
ORCID	Author(s) ORCID Number Xiao-Chen Feng http://orcid.org/0000-0003-3204-3622 Hui Liu http://orcid.org/0000-0003-4599-5702
Funding Agency and Grant Number	Funding Agency Grant Number National Natural Science Foundation of China No. 82270634 Third Affiliated Hospital of Naval Medical University No. tf2024yzyy01
Corresponding Author	Hui Liu, The Third Department of Hepatic Surgery, Eastern Hepatobiliary Surgery Hospital, No. 225 Changhai Road, Shanghai 200082, China. liuhuigg@hotmail.com
Key Words	Hepatocellular carcinoma; Tumor recurrence; Radiotherapy; Targeted Therapy; Immunotherapy; Treatment strategies
Core Tip	Hepatocellular carcinoma (HCC) is a prevalent cancer worldwide, ranking as the third leading cause of cancer-related deaths. Despite advancements in treatment modalities, a significant proportion of patients with HCC (50%-70%) experience tumor recurrence within 5 years of initial treatment. This review focuses on the roles of radiotherapy, targeted therapy, and immunotherapy in managing post-surgical HCC recurrence and their combined effects.
Publish Date	2025-07-14 12:56
Citation	<p>Liu QJ, Zhang JC, Wang YF, Zou MH, Zhou WX, Lu Y, Feng XC, Liu H. Correlation of radiotherapy, targeted therapy, and immunotherapy with hepatocellular carcinoma recurrence. <i>World J Gastrointest Oncol</i> 2025; 17(7): 107815</p>
URL	https://www.wjgnet.com/1948-5204/full/v17/i7/107815.htm
DOI	https://dx.doi.org/10.4251/wjgo.v17.i7.107815

Full Article (PDF)	WJGO-17-107815-with-cover.pdf
Manuscript File	107815_Auto_Edited_065802.docx
Answering Reviewers	107815-answering-reviewers.pdf
Audio Core Tip	107815-audio.mp3
Conflict-of-Interest Disclosure Form	107815-conflict-of-interest-statement.pdf
Copyright License Agreement	107815-copyright-assignment.pdf
Approved Grant Application Form(s) or Funding Agency Copy of any Approval Document(s)	107815-foundation-statement.pdf
Non-Native Speakers of English Editing Certificate	107815-non-native-speakers.pdf
Peer-review Report	107815-peer-reviews.pdf
Scientific Misconduct Check	107815-scientific-misconduct-check.png
Scientific Editor Work List	107815-scientific-editor-work-list.pdf
CrossCheck Report	107815-crosscheck-report.pdf